Skip to content

Christopher Kent

CEO, ODS Medical

Chris has served as the CEO of ODS Medical since its’ founding in 2015. ODS Medical is commercializing an unique Raman spectroscopy system for real-time, intra-operative tissue characterization during surgery. Prior to ODS Medical, he worked with Dr. Kevin Petrecca, building a translational research program at the Montreal Neurological Institute focused on working with industry partners to accelerate the discovery and pre-clinical development of treatments for brain cancers. He also did his PhD at McGill in Neuroscience and has published numerous peer-reviewed journal articles.